Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 56

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 56
---
 
 Value of 
      New 
   Vested 
   Awards |     |        Plus 
   Change in 
    Value of 
 Prior Years 
      Vested 
      Awards |     |        Equals 
  Compensation 
 Actually Paid |
| 2024       |     | $1,781,092 |     | -$1,059,756 |     | $1,185,088 |     |     $26,653 |     | $239,935 |     |     $34,711 |     |    $2,207,723 |
| 2023       |     | $1,692,632 |     |   -$915,819 |     |   $678,960 |     |     $17,908 |     | $117,349 |     |      $3,047 |     |    $1,594,078 |
| 2022       |     | $1,281,722 |     |   -$664,192 |     |   $422,898 |     |   -$275,062 |     | $138,705 |     |   -$157,356 |     |      $746,716 |

Compensation Actually Paid and Cumulative Total Shareholder Return The graph below compares the compensation actually paid to our PEO and the average of the compensation actually paid to our remaining NEOs, with our cumulative total shareholder return for the fiscal years ended December 31, 2022, 2023 and 2024. Total Shareholder Return amounts reported in the graph assume an initial fixed investment of $100 on December 31, 2021.

34

TABLE OF CONTENTS Compensation Actually Paid and Net Loss The graph below compares the compensation actually paid to our PEO and the average of the compensation actually paid to our remaining NEOs, with our net loss for the fiscal years ended December 31, 2022, 2023 and 2024. Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information Although we do not have a formal policy, program or plan that requires us to award equity or equity-based compensation on specific dates, we generally issue equity awards to our employees, including our executive officers, annually in the first quarter, and such awards are approved by our Compensation Committee during the first quarter. In certain circumstances, including the hiring of an employee, the Compensation Committee may approve grants to be effective at other times. Our Board and Compensation Committee does not take material nonpublic information into